Exosome nanovesicles as potential biomarkers and immune checkpoint signaling modulators in lung cancer microenvironment: recent advances and emerging …

NA Khan, M Asim, KH Biswas, AN Alansari… - Journal of Experimental …, 2023 - Springer
Lung cancer remains the leading cause of cancer-related deaths globally, and the survival
rate remains low despite advances in diagnosis and treatment. The progression of lung …

Extracellular vesicle-based liquid biopsy biomarkers and their application in precision immuno-oncology

K Asleh, V Dery, C Taylor, M Davey… - Biomarker …, 2023 - Springer
While the field of precision oncology is rapidly expanding and more targeted options are
revolutionizing cancer treatment paradigms, therapeutic resistance particularly to …

Immunotherapeutic effect of photothermal-mediated exosomes secreted from breast cancer cells

M Najaflou, F Bani, AY Khosroushahi - Nanomedicine, 2023 - Taylor & Francis
Aim: Exosomal damage-associated molecular patterns can play a key role in
immunostimulation and changing the cold tumor microenvironment to hot. Materials & …

Tumor cell membrane‐based vaccines: a potential boost for cancer immunotherapy

M Yang, J Zhou, L Lu, D Deng, J Huang, Z Tang… - …, 2024 - Wiley Online Library
Because therapeutic cancer vaccines can, in theory, eliminate tumor cells specifically with
relatively low toxicity, they have long been considered for application in repressing cancer …

Extracellular Vesicles, Circulating Tumor Cells, and Immune Checkpoint Inhibitors: Hints and Promises

S Bandini, P Ulivi, T Rossi - Cells, 2024 - mdpi.com
Immune checkpoint inhibitor (ICI) therapy has revolutionized the treatment of cancer, in
particular lung cancer, while the introduction of predictive biomarkers from liquid biopsies …

[HTML][HTML] Advancements in Personalized CAR-T Therapy: Comprehensive Overview of Biomarkers and Therapeutic Targets in Hematological Malignancies

W Olejarz, K Sadowski, D Szulczyk… - International Journal of …, 2024 - mdpi.com
Chimeric antigen receptor T-cell (CAR-T) therapy is a novel anticancer therapy using
autologous or allogeneic T-cells. To date, six CAR-T therapies for specific B-cell acute …

Role of Exosomes in Cancer and Aptamer-Modified Exosomes as a Promising Platform for Cancer Targeted Therapy

Y Wu, Y Cao, L Chen, X Lai, S Zhang… - Biological Procedures …, 2024 - Springer
Exosomes are increasingly recognized as important mediators of intercellular
communication in cancer biology. Exosomes can be derived from cancer cells as well as …

Glucocorticoids in Lung Cancer: Navigating the Balance Between Immunosuppression and Therapeutic Efficacy

W Xu, J Ye, Z Cao, Y Zhao, Y Zhu, L Li - Heliyon, 2024 - cell.com
Glucocorticoids (GCs), a class of hormones secreted by the adrenal glands, are released
into the bloodstream to maintain homeostasis and modulate responses to various stressors …

[HTML][HTML] Mechanisms and characteristics of subcapsular sinus macrophages in tumor immunity: a narrative review

F Su, Y Zhang, S Maimaiti, S Chen, Y Shen… - Translational Cancer …, 2023 - ncbi.nlm.nih.gov
Methods A systematic search was conducted in PubMed and Web of Science to identify
articles investigating clinical significance and mechanisms of SCSMs. Study eligibility was …

Human Umbilical Vein Endothelial Cells as a Versatile Cellular Model System in Diverse Experimental Paradigms: An Ultrastructural Perspective

H Duranova, L Kuzelova, P Borotova… - Microscopy and …, 2024 - academic.oup.com
Human umbilical vein endothelial cells (HUVECs) are primary cells isolated from the vein of
an umbilical cord, extensively used in cardiovascular studies and medical research. These …